PRO instrument portal for MCL study

Use this portal to launch the ePROs for the trial participants on the tablet

We are seeking participants for Phase 3 Clinical Trial. This study aims to evaluate the effectiveness and safety of BGB-16673 compared to the standard treatment options for relapsed/refractory Mantle Cell Lymphoma. Below you will find important information how to enroll.

Instructions for site:

  • Participant Check-In: When the Participant arrives at site enter the Participant ID, Visit number and ePRO Language.
  • Launch ePRO Form: Initiate the electronic Patient-Reported Outcome (ePRO) form upon submission of the Participant profile information.
  • Participant Input: Hand the iPad/tablet to the Participant for them to independently complete the ePRO form.
  • Submission: Once the Participant finishes the form, ensure all responses are accurately recorded, and submit the form.
  • Review: Verify the submitted ePRO form for completeness and accuracy.
  • End Session: Conclude the ePRO session and return the iPad/tablet to its designated location.
{{ failureMessage }}

Participant Profile

{{ errors.participant_id[0] }}
{{ errors.visit[0] }}
{{ errors.survey_package_id[0] }}

Technical Support

  • If you encounter any issues or need technical assistance with the ePRO Administration Portal, please contact helpdesk at phone number +1(123456789) or send an email to support@studyenrolment.com
Signing up for more information places you under no obligation to participate in this study. Any information you provide will be kept strictly confidential and will not be shared without your permission except as required by law.
MCL study
loading...